Back to search

Netherlands· NL-70156feb31c1

Rosuvastatine/Ezetimibe Viatris Healthcare 40 mg/10 mg filmomhulde tabletten

A rosuvastatin and ezetimibe product containing ezetimib + rosuvastatine calcium 0-water, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 9 of our 19 countries.

ATC C10BA06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRosuvastatine/Ezetimibe Viatris Healt…ATCC10BA06REGISTER NO.NL-70156feb31c1PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Rosuvastatin and ezetimibe is registered in 9 of 19 countries.

Countries holding a registration under ATC C10BA06 (rosuvastatin and ezetimibe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Rosuvastatin and ezetimibe · ATC C10BA06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EZETIMIB + ROSUVASTATINE CALCIUM 0-WATER
Manufacturer
Viatris Healthcare Limited
Country
Netherlands (NL)
ATC code
C10BA06
ATC class
Rosuvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130991

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin and ezetimibe in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Arosuva Plus Ezetimib, Ezerosu
  • Belgium · Cholecomb, Ezetimibe/Rosuvastatin Sandoz
  • Bulgaria · Rosteza 10 Mg/10 Mg, Rosteza 20 Mg/10 Mg
  • Cyprus · Celmantin Plus, Lipocomb
  • Czechia · Delipid Plus, Refidoro
  • Germany · Antilia, Ezehron Duo
  • Estonia · Delipid Plus, Rosazimib
  • Spain · Alzil Plus, Arrox Plus
  • Finland · Rosuvastatin/Ezetimib Krka, Rosuvastatin/Ezetimibe Ratiopharm
  • France · Liporosa, Quiloga
  • Greece · Celmantin Plus, Co-Rosuvador
  • Croatia · Arosen, Co-Roswera
  • Hungary · Co-Xeter, Delipid Plus
  • Ireland · Lipocomb, Rosuvastatin/Ezetimibe Krka
  • Italy · Aurozeb, Cholecomb
  • Lithuania · Roselia, Sorvitimb
  • Luxembourg · Cholecomb, Myrosor
  • Latvia · Rosazimib, Rosulip
  • Malta · Ezehron Duo, Lipocomb
  • Norway · Rosteze, Rosuvastatin/Ezetimib Krka
  • Poland · Coroswera, Ezehron Duo
  • Portugal · Colroset, Lipocomb
  • Romania · Co-Roswera, Lipocomb
  • Slovenia · Refidoro, Rozor
  • Slovakia · Lipocomb, Rosazimib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8fe1265-b3b7-44ed-988c-47084b49991b
GET /v1/drugs/f8fe1265-b3b7-44ed-988c-47084b49991b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130991_smpc.pdf",
  "strength": null,
  "atc_label": "Rosuvastatin and ezetimibe",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130991",
  "excipients": [
    "BUTYLHYDROXYANISOL (E 320)",
    "CALCIUMWATERSTOFFOSFAAT 2-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "MEGLUMINE",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMSTEARYLFUMARAAT",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EZETIMIB",
    "ROSUVASTATINE CALCIUM 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130991.pdf",
  "authorised_at": "2025/11/13",
  "procedure_number": "NL/H/4175/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130991",
  "additional_monitoring": "N"
}

See everything about rosuvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.